We then examined how ribociclib and IL-15 cytokine signals impact CD8 + T cell regulation of cancer population growth by experimentally coculturing patient-derived T cells with one of four fluorescently labeled cancer cell lines (ribociclib resistant vs sensitive CAMA-1 and MDA-MB-134 cells; non-autologous). The gene discussed is CD8A; the disease is cancer.